Related Experiment Videos
Class II major histocompatibility complex and organ specific autoimmunity in man
The Journal of Pathology
|September 1, 1986
Summary
Aberrant expression of class II major histocompatibility complex (MHC) antigens may initiate autoimmune diseases. This occurs when target cells present antigens to T helper lymphocytes, potentially breaking immune tolerance.
Area of Science:
- Immunology
- Autoimmunity
- Cellular Biology
Background:
- T helper lymphocytes require antigen presentation by cells expressing compatible class II major histocompatibility complex (MHC) molecules.
- Normally, target cells in organ-specific autoimmune diseases lack surface class II MHC, preventing antigen presentation and maintaining immune tolerance.
- Aberrant expression of class II MHC on target cells has been observed in several autoimmune diseases.
Purpose of the Study:
- To investigate the role of aberrant class II MHC expression in initiating organ-specific autoimmune diseases.
- To explore the mechanism by which cell-specific antigens are presented to T helper lymphocytes in autoimmunity.
Main Methods:
- The study discusses the immunological principles of antigen presentation and T cell recognition.
- It reviews evidence of aberrant class II MHC expression in target cells of autoimmune diseases.
- The proposed mechanism involves the presentation of cell-specific antigens to autoreactive T helper lymphocytes.
Main Results:
- Aberrant expression of class II MHC on target cells can lead to the presentation of cell-specific antigens.
- This presentation may overcome immunological tolerance to self-antigens.
- Potentially autoreactive T helper lymphocytes can be activated by these presented antigens.
Conclusions:
- Aberrant expression of class II MHC antigens is proposed as a potential initiating factor in certain organ-specific autoimmune diseases.
- The aberrant expression facilitates the presentation of cell-specific antigens, potentially breaking immune tolerance and triggering autoimmune responses.